Feiyiliu Mixture sensitizes EGFRDel19/T790M/C797S mutant non-small cell lung cancer to osimertinib by attenuating the PRC1/Wnt/EGFR pathwayJingjing Shi, Xin Zheng|Frontiers in Pharmacology|2023Cited by 13